Janney Montgomery Scott
RPRX icon

Janney Montgomery Scott’s Royalty Pharma RPRX Stock Holding History

Janney Montgomery Scott’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$396K Sell
8,258
-149
-2% -$6.53K ﹤0.01% 2200
2025
Q4 		$325K Buy
8,407
+2,044
+32% +$77.9K ﹤0.01% 2504
2025
Q3 		$224K Buy
+6,363
New +$230K ﹤0.01% 2674
2023
Q4 		– Sell
-18,972
Closed -$515K – 2737
2023
Q3 		$515K Sell
18,972
-811
-4% -$24.1K ﹤0.01% 1746
2023
Q2 		$608K Buy
+19,783
New +$670K ﹤0.01% 1714
2022
Q2 		– Sell
-6,422
Closed -$250K – 2418
2022
Q1 		$250K Sell
6,422
-102
-2% -$4K ﹤0.01% 1977
2021
Q4 		$260K Buy
+6,524
New +$253K ﹤0.01% 2084

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Janney Montgomery Scott's RPRX Position: Q1 2026 in Review

Janney Montgomery Scott reduced its Royalty Pharma (RPRX) stake by 1.8% in Q1 2026, selling an estimated $6.53K and leaving 8,258 shares worth $396K. The position accounts for ﹤0.01% of the portfolio, ranked #2200.

Janney Montgomery Scott first reported a position in RPRX in Q4 2021 and has held it in 7 quarters since. The position peaked at $608K in Q2 2023. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Janney Montgomery Scott held 8,258 shares of Royalty Pharma worth $396K as of Q1 2026.
  • Janney Montgomery Scott sold 149 Royalty Pharma shares in Q1 2026, an estimated $6.53K.
  • Royalty Pharma made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #2200 holding.
  • Janney Montgomery Scott first reported a position in Royalty Pharma in Q4 2021 and has held it in 7 quarters since.
  • Janney Montgomery Scott's Royalty Pharma position peaked at $608K in Q2 2023.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.